✦ LIBER ✦

Neuroblastoma maturation by [131I] metaiodobenzylguanidine in chemoresistant neuroblastoma

✍ Scribed by Arush, M. Weyl Ben; Itzhak, O. Ben; Yossilevski, G.; El Hasid, R.; Postovsky, S.; Israel, O.

Publisher: John Wiley and Sons
Year: 1999
Tongue: English
Weight: 136 KB
Volume: 33
Category: Article
ISSN: 0098-1532
DOI: 10.1002/(sici)1096-911x(199910)33:4<418::aid-mpo18>3.0.co;2-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of neuroblastoma with131I-meta

Treatment of neuroblastoma with131I-metaiodobenzylguanidine

✍ Troncone, L. ;Riccardi, R. ;Montemaggi, P. ;Rufini, V. ;Lasorella, A. ;Mastrange 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 345 KB

Seven patients with neuroblastoma (six children and one adult) were treated with therapeutic doses of high specific activity 131I-metaiodobenzylguanidine (131I-MIBG). Six patients were in stage IV and unresponsive to conventional treatment. One patient, in stage III, was treated at diagnosis, an app

I-131 metaiodobenzylguanidine: Diagnosti

I-131 metaiodobenzylguanidine: Diagnostic use in neuroblastoma patients in relapse

✍ Heyman, Sydney ;Evans, Audrey E. ;D'Angio, Giulio J. 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 420 KB

Metaiodobenzylguanidine (MIBG) has been used for the detection and treatment of neuroectodermal tumors, including neuroblastoma. We report our experience with I3'l- MIBG used diagnostically in neuroblastoma patients with relapse. Thirtyeight studies were performed in 26 patients. There were 24 child

131I-metaiodobenzylguanidine treatment i

131I-metaiodobenzylguanidine treatment in neuroblastoma: Report of two cases

✍ Cottino, F. ;Mussa, G. C. ;Madon, E. ;Favero, A. ;Silvestro, L. ;Grazia, G. 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 265 KB

Poor results with 131I-meta-iodobenzylguanidine (MIBG) therapy have been obtained in two children with stage IV neuroblastoma treated after partial surgery and unsatisfactory combination chemotherapy. Both patients' response to treatment (four and three 1-month-spaced courses, respectively; cumulati

Position paper: Role of131I-metaiodobenz

Position paper: Role of131I-metaiodobenzylguanidine in the treatment of neuroblastoma

✍ Mastrangelo, Renato; Tornesello, Assunta; Mastrangelo, Stefano 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB 👁 1 views

Background. Standard chemo-radiotherapy methods for the treatment of children with advanced neuroblastoma (NBL) including bone marrow transplant approaches have been disappointing. These poor results can be ascribed to the evolution of residual drug-resistant cell populations. Curative attempts shou

Considerations on131I-metaiodobenzylguan

Considerations on131I-metaiodobenzylguanidine therapy of six children with neuroblastoma

✍ Sanguineti, Michele 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB

Six children affected by neuroblastoma at stages III and IV were treated with high-specific-activity 131I-metaiodobenzylguanidine (MIBG). After 131I-MIBG treatment three patients died at 12, 10, and 12 weeks, respectively; the other three were still living at 21, 16, and 24 weeks, respectively. Alth

Second malignancies in children with neu

Second malignancies in children with neuroblastoma after combined treatment with 131I-metaiodobenzylguanidine

✍ Alberto Garaventa; Claudio Gambini; Giampiero Villavecchia; Andrea Di Cataldo; L 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

## Abstract ## BACKGROUND ^131^I‐metaiodobenzylguanidine (^131^I‐MIBG) is selectively taken up by cells of neural crest origin, allowing targeted radiotherapy of tumors such as neuroblastoma (NB) and pheochromocytoma. Radiotherapy may provide additional benefits in the treatment of NB, with modera